Earnings Reports — November 02, 2026 — Midday Update — Last 24 Hours (Pacific Time)

Executive Summary

The earnings season is delivering a broadly positive tone, with most companies that have reported actual results coming in ahead of expectations — though a handful of high-profile misses are generating outsized market reactions. Stock moves are dramatic on both ends: Alstom cratered 28%, NAPCO Security tumbled 20%, and Check Point Software fell 9%, while Estée Lauder, Fox Corp, and Marriott International all surged on beats and raised guidance. Key themes include AI-driven demand across semiconductors and optics, data center power infrastructure, travel & hospitality resilience, and ongoing pressure in cybersecurity, building products, and energy.

Earnings Performance Breakdown

Note: Only headlines reporting actual results are classified below. The large majority of headlines (items 4–143, and several others) are earnings previews — they are excluded from classification. Actual results reported in the last 24 hours are classified here.

Summary Count (Actual Results Only)

Notable Earnings Reports

🔴 Alstom — Miss / Outlook Cut

• Stock plunged ~28% after the French rail company again cut its outlook, citing Coradia Max execution issues.
• This is a significant warning for European industrial investors; repeated guidance cuts signal deeper operational problems.

🟢 Fox Corporation — Double Beat

• EPS of $2.54, beating estimates by $0.48; revenue also topped expectations. Stock gained.
• Tubi streaming growth and advertising strength drove the outperformance in fiscal Q1 2027.

🟢 Estée Lauder — Double Beat + Raised Outlook

• EPS of $0.72, beating by $0.21; revenue topped estimates. Stock jumped on the raised outlook.
• A China recovery narrative appears to be gaining traction, a key watch item for luxury consumer sentiment.

🔴 NAPCO Security — Double Miss

• EPS of $0.34, missed by $0.04; revenue also fell short. Stock tumbled ~20%.
• The recurring revenue model came under pressure, a sharp reversal for a company that had been a market darling.

🟢 Marriott International — Double Beat + Raised Guidance

• EPS of $3.02, beating by $0.19; revenue topped estimates. Shares rose over 3% in premarket.
• The hotel giant raised its full-year RevPAR forecast, signaling continued travel demand resilience.

🟢 IDEXX Laboratories — Double Beat + Raised Guidance

• EPS of $3.96, beating by $0.24; revenue topped estimates; guidance raised. Stock gained.
• Innovation is helping offset softer vet visit volumes — a positive signal for the animal health sector.

🔴 Check Point Software — Mixed / Effectively a Miss

• EPS matched at $2.49, but revenue fell short. Stock fell ~9%.
• Sales execution concerns are weighing heavily; the market is clearly demanding top-line growth, not just margin management.

🟢 Lumentum Holdings — Double Beat

• EPS of $4.57, beating by $0.36; revenue topped estimates.
• AI optics demand appears to be a genuine tailwind for the optical components sector.

🔴 Ryanair — Miss + Profit Warning

• H1 profit fell 15%; company warned of a ~€2 billion higher fuel bill starting April 2027.
• A major headwind for European aviation; fuel cost inflation is resurfacing as a sector-wide concern.

🟢 Immunovia — Strong Beat

• Stock surged ~13% after strong Q3 sales growth driven by its PancreaSure pancreatic cancer detection test.
• Early commercial traction in diagnostics is a meaningful signal for the liquid biopsy/cancer detection space.

Sector Analysis

🟢 Hospitality & Travel — Strength
Marriott (beat + raised guidance), Choice Hotels (beat + raised RevPAR outlook), and Loews all delivered positive results. Travel demand remains robust heading into year-end.

🟢 Media & Streaming — Strength
Fox Corp delivered a significant beat driven by advertising and Tubi streaming. The ad market appears healthier than feared.

🟢 Biopharma & Life Sciences — Mixed-to-Positive
Axsome Therapeutics, Krystal Biotech, and Grifols all beat. Immunovia surged 13%. However, Krystal fell ~4% despite its beat — suggesting elevated expectations in the space. Multiple biopharma previews (Vertex, Neurocrine, BioNTech, Madrigal) are due imminently.

🟢 AI & Semiconductors — Broadly Positive
Lumentum (AI optics), Tower Semiconductor (mixed but strong Q4 guidance), and Tempus AI (beat + raised guidance) all point to continued AI infrastructure spending. Kyocera's H1 profit jumped 56% on AI demand even as its quarterly result missed.

🔴 Cybersecurity — Weakness
Check Point Software's 9% drop on a revenue miss highlights that the cybersecurity sector is not immune to sales execution challenges despite strong secular demand.

🔴 European Industrials & Building Products — Weakness
Alstom (–28%), Ibstock (–10%), and Bakkafrost (–5%) all disappointed. Execution issues and profit warnings are clustering in European industrial and materials names.

🔴 Energy — Mixed-to-Weak
Kosmos Energy sank on a double miss. Ryanair's fuel cost warning adds pressure to energy-sensitive sectors. Multiple energy earnings previews (Marathon Petroleum, Diamondback, Energy Transfer) are pending.

🟡 Utilities — Mixed
Entergy beat on EPS but missed on revenue. Public Service Enterprise missed on both. Data center demand is a tailwind narrative for utilities, but near-term results are uneven.

Biggest Movers

Market Implications

The beat rate among companies that have actually reported (~46% double beats vs. ~29% double misses) suggests earnings season remains constructive, but the market is punishing misses severely — Check Point's 9% drop on a mere revenue miss and NAPCO's 20% collapse illustrate that investor tolerance for disappointment is thin. This asymmetry is typical of a late-cycle environment where valuations are elevated and expectations are high.

The AI infrastructure theme continues to show up in actual results, not just narratives. Lumentum's optics beat, Tower Semiconductor's strong Q4 guidance, Tempus AI's raised outlook, and Kyocera's H1 profit surge all validate that spending on AI-related hardware and components is translating into real revenue. Investors should watch Tuesday's semiconductor and tech previews closely — Lattice Semiconductor, Fabrinet, and Advanced Energy are all reporting after the close.

On the macro side, Ryanair's €2 billion fuel cost warning is a notable flag for global aviation and energy-sensitive businesses. Meanwhile, the hospitality sector's strong showing (Marriott, Choice Hotels) suggests the consumer remains willing to spend on experiences — a potentially important signal ahead of the holiday season. Tuesday brings a heavy slate including Pfizer, Shopify, Eaton, Apollo Global, Ferrari, and Berkshire Hathaway, which will significantly shape the week's earnings narrative.

Key Takeaways

• 🔴 Alstom (ALO) — A 28% single-day collapse on a repeated outlook cut is a red flag for European industrial execution risk; avoid until management credibility is restored.
• 🔴 NAPCO Security (NSSC) — A 20% drop on a modest miss signals the stock was priced for perfection; recurring revenue models need to actually recur.
• 🟢 Fox Corp (FOXA/FOX) — A $0.48 EPS beat driven by Tubi and advertising strength suggests the streaming ad market is healthier than feared.
• 🟢 Marriott (MAR) — Beat plus raised RevPAR guidance confirms travel demand is holding; a positive read-through for the broader hospitality sector.
• 🟢 Estée Lauder (EL) — Beat and raised outlook with China recovery in focus; luxury consumer sentiment may be turning a corner.
• 🔴 Check Point Software (CHKP) — A 9% drop on a revenue miss despite in-line EPS shows the market wants growth, not just margin discipline, in cybersecurity.
• 🟢 Lumentum (LITE) — A $0.36 EPS beat validates AI optics demand as a real revenue driver, not just a theme.
• 🟢 IDEXX Labs (IDXX) — Beat and raised guidance despite softer vet visit volumes; innovation is winning over macro headwinds in animal health.
• 🔴 Ryanair (RYA) — €2B fuel cost warning for FY2028 is a material headwind for European aviation; watch for read-through to other carriers.
• 🟢 Tempus AI (TEM) — Beat plus raised guidance in precision medicine; AI-driven healthcare data is monetizing faster than expected.
• 🔴 Kosmos Energy (KOS) — Double miss after a 200% stock rally is a classic "buy the rumor, sell the news" unwind; valuation had run far ahead of fundamentals.
• 🟢 Immunovia — +13% on PancreaSure sales growth; early commercial traction in cancer diagnostics is a meaningful signal for the liquid biopsy space.
• 🟢 Sumitomo (8053) — Raised full-year forecast after Q2 growth; Japanese trading houses continue to benefit from diversified commodity and industrial exposure.
• 🔴 Ibstock — Second profit warning of 2026 in UK building products; construction sector headwinds in Europe are not abating.
• 🟡 Tower Semiconductor (TSEM) — Slight EPS miss but strong Q4 guidance and stock up; the forward outlook matters more than the backward quarter in semis.
• ⚠️ Tuesday is a massive earnings day — Pfizer, Shopify, Ferrari, Apollo Global, Eaton, Marathon Petroleum, and Berkshire Hathaway all report; position sizing ahead of these prints warrants caution.

Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.

👉 This is not financial advice. Market conditions change rapidly.
Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/